Literature DB >> 11557179

Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study.

C E Ruhl1, A Sonnenberg, J E Everhart.   

Abstract

PURPOSE: Hiatal hernia and reflux esophagitis have been associated with respiratory manifestations, though the temporal sequence of this relationship is uncertain. This study examined prospectively the relationship of hiatal hernia and reflux esophagitis with respiratory outcomes in a representative sample of the United States population.
METHODS: 6928 participants in the first National Health and Nutrition Examination Survey, a population-based sample initially examined in 1971-1975, who were hospitalized during follow-up through 1992-1993 composed the study population. The relationship between hiatal hernia and reflux esophagitis hospitalization and a subsequent hospitalization with respiratory outcomes was measured in persons free of respiratory disease at baseline and at first hospitalization.
RESULTS: Multivariable survival analysis showed higher rates of hospitalization with any respiratory diagnosis [rate ratio (RR) = 1.4, 95% confidence interval (CI) 1.2-1.7] in persons with preceding hiatal hernia or reflux esophagitis hospitalization. Individually, rate ratios of pharyngitis (RR = 5.6, CI 2.0-15.7), tonsillitis (RR = 8.0, CI 2.5-25.8), bronchitis (RR = 1.8, CI 1.2-2.7), pneumonia (RR = 1.3, CI 1.0-1.7), emphysema (RR = 2.9, CI 1.5-5.5), asthma (RR = 2.1, CI 1.1-4.2), bronchiectasis (RR = 6.2, CI 1.1-34.3), and empyema or abscess (RR = 7.4, CI 1.3-42.3) were all higher following hiatal hernia and reflux esophagitis. Rate ratios were similar when reflux esophagitis and hiatal hernia were examined separately.
CONCLUSIONS: A prior hiatal hernia or reflux esophagitis hospitalization increased risk of respiratory disease hospitalization.

Entities:  

Mesh:

Year:  2001        PMID: 11557179     DOI: 10.1016/s1047-2797(01)00236-8

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  6 in total

Review 1.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

2.  Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.

Authors:  Jason E Lang; Janet T Holbrook; Edward B Mougey; Christine Y Wei; Robert A Wise; W Gerald Teague; John J Lima
Journal:  Ann Am Thorac Soc       Date:  2015-06

3.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

Review 4.  The frontiers of reflux disease.

Authors:  Nimish Vakil
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

Review 5.  The association between gastro-oesophageal reflux disease and asthma: a systematic review.

Authors:  B D Havemann; C A Henderson; H B El-Serag
Journal:  Gut       Date:  2007-08-06       Impact factor: 23.059

6.  Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications.

Authors:  Michael F Kaminski; Theresa Ermer; Maureen Canavan; Andrew X Li; Richard C Maduka; Peter Zhan; Daniel J Boffa; Meaghan Dendy Case
Journal:  JTCVS Open       Date:  2022-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.